samograj - 2008-11-05 20:26:06

Phase I Study of Lonafarnib (TARCEVA) and Temozolomide (TEMODAL) in Patients With Recurrent Primary Supratentorial Gliomas.

http://www.cancer.gov/clinicaltrials/EORTC-16027

TŁUMACZ POSZUKIWANY!!!!

weekend w spa Ciechocinek